Related Experiment Videos
Multiple Sclerosis: Epidemiologic, Clinical, and Therapeutic Aspects
Angela Vidal-Jordana1, Xavier Montalban1
1Department of Neurology-Neuroimmunology, Multiple Sclerosis Centre of Catalonia, Edifici Cemcat, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Ps Vall d'Hebron 119-129, Barcelona 08035, Spain.
Neuroimaging Clinics of North America
|April 11, 2017
Summary
Multiple sclerosis (MS) is a chronic autoimmune central nervous system disease affecting young adults. Optimal management involves patient-doctor collaboration due to diverse treatment options and individual risk-benefit profiles.
Area of Science:
- Neurology
- Immunology
- Genetics
Background:
- Multiple sclerosis (MS) is a chronic, autoimmune, and degenerative central nervous system disease primarily affecting young individuals.
- MS pathogenesis involves genetic susceptibility and unknown environmental triggers, leading to varied clinical presentations.
- The disease commonly manifests as relapsing-remitting (85%) or primary progressive (15%) courses.
Purpose of the Study:
- To review the current landscape of disease-modifying treatments for multiple sclerosis.
- To highlight the challenges faced by neurologists in selecting appropriate treatments based on individual risk-benefit profiles.
- To emphasize the importance of patient involvement in treatment decisions for adherence and safety.
Main Methods:
- Literature review of current multiple sclerosis phenotypes and disease-modifying therapies.
- Analysis of treatment selection criteria, including risk-benefit assessments.
- Discussion of patient-centered care models in managing chronic neurological conditions.
Main Results:
- An expanding array of disease-modifying treatments is available for multiple sclerosis.
- Each treatment option presents a unique risk-benefit profile, complicating clinical decision-making.
- Patient engagement in the decision-making process is crucial for treatment adherence and safety.
Conclusions:
- Effective management of multiple sclerosis requires careful consideration of diverse treatment options.
- Shared decision-making between patients and neurologists is essential for optimizing therapeutic outcomes and monitoring.
- Personalized treatment strategies are key to managing the complexities of multiple sclerosis.